The level of this enzyme is elevated in Fragile X syndrome (FXS), in which inattention, impulsivity and hyperactivity are manifested beside autism, and administration of minocycline (MMP-9 inhibitor) to mouse model of FXS results in normalization of behaviours and a decrease in anxiety [83]. This evidence concerns the gene MMP9 and Anxiety.